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Abstract
Introduction: Hospital readmission rates are increasingly used for both quality improvement and cost control. However,
the validity of readmission rates as a measure of quality of hospital care is not evident. We aimed to give an overview of the
different methodological aspects in the definition and measurement of readmission rates that need to be considered when
interpreting readmission rates as a reflection of quality of care.
Methods: We conducted a systematic literature review, using the bibliographic databases Embase, Medline OvidSP, Web-
of-Science, Cochrane central and PubMed for the period of January 2001 to May 2013.
Results: The search resulted in 102 included papers. We found that definition of the context in which readmissions are used
as a quality indicator is crucial. This context includes the patient group and the specific aspects of care of which the quality
is aimed to be assessed. Methodological flaws like unreliable data and insufficient case-mix correction may confound the
comparison of readmission rates between hospitals. Another problem occurs when the basic distinction between planned
and unplanned readmissions cannot be made. Finally, the multi-faceted nature of quality of care and the correlation
between readmissions and other outcomes limit the indicator’s validity.
Conclusions: Although readmission rates are a promising quality indicator, several methodological concerns identified in
this study need to be addressed, especially when the indicator is intended for accountability or pay for performance. We
recommend investing resources in accurate data registration, improved indicator description, and bundling outcome
measures to provide a more complete picture of hospital care.
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Background
Readmissions cause a high burden to healthcare systems and
patients. In the US nearly 20% of Medicare patients are
readmitted within 30 days after hospital discharge, associated
with an estimated annual cost of 17billion [1]. Readmissions are
thought to be related to quality of care, for instance due to
postoperative complications. As readmissions vary widely across
countries, regions and centers, at least part of them might be
avoidable [2–6]. As a consequence, there is a high interest in the
readmission rate as an indicator of quality of hospital care.
Nevertheless, the actual way this indicator is used in different
countries varies widely.
In the US, since 2009 all-cause hospital readmission rates for
pneumonia, congestive heart failure, and acute myocardial
infarction are publically reported by the Centers for Medicare
and Medicaid Services (CMS) [7]. In 2010, the Patient Protection
and Affordable Care Act (ACA) introduced the Hospital
Readmissions Reduction Program (HRRP), for cost controlling.
The program included financial penalties for hospitals having high
readmission rates, which will be extended in the coming years [8].
In the UK, readmission rates for specific diseases have been
published since 1998 by the National Centre for Health Outcomes
Development (NCHOD) to improve quality [9]. It was found that
the crude emergency readmission rate had increased from about
8% in 1998 to about 10% in 2006 [9]. In response, the NHS
started a new regulation for reimbursement payments in 2011:
hospitals receive no reimbursement for emergency readmissions
within 30 days of discharge following an elective admission. All
other emergency readmissions are reimbursed for only 25% [10].
Since the year 2006 also the Australian government monitors 28-
day readmission rates to gain more insight in quality of care [11].
Readmissions are used for different aims, such as cost control or
as balancing measure for length of hospital stay or other outcome
measures. However, in recent years the focus has primarily been
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on using it as an easily available measure of the quality of hospital
care. Despite its use by policymakers for both quality improvement
and cost control, the validity of readmission rates as a measure of
quality of hospital care is not evident [12].
However, in order to consider a quality indicator to evaluate
care for external purposes it needs to fulfill certain criteria in
regards to its reliability and validity. An indicator needs to show
relevance, based on its impact on health, its importance for policy
and its susceptibility to being influenced by the health care system.
The assessment of an indicator needs to be feasible. The data
needed to calculate an indicator need to be available, reliable and
need to be seen in relation to the burden of reporting. Further, an
indicator needs to show scientific soundness [13]. In the case of the
readmission rate, this suggests, that readmissions are determined
by quality of hospital care, measured by structures and processes.
This implies that we are interested in avoidable readmissions.
We aim to give an overview of the different methodological
aspects in the definition and measurement of readmission rates
that need to be considered when interpreting readmission rates as
a reflection of quality of hospital care for external purposes.
Methodology
A systematic computerized literature search was applied in the
bibliographic databases Embase, Medline OvidSP, Web-of-
Science, Cochrane central and PubMed for the period of 1st
January 2001 to 27th May 2013.
With the search terms we aimed to cover quality indicators,
quality measurement and readmission. This resulted in the
following search strategy, which was adapted for the different
bibliographic databases: (‘clinical indicator’/de OR ‘performance
measurement system’/exp OR ‘quality control procedures’/de
OR ‘quality control’/de OR ‘medical audit’/de OR (((qualit* OR
perform* OR safet* OR governance) NEAR/3 (indicat* OR
measure* OR assessment* OR control* OR marker* OR metric*))
OR ((clinical OR medical) NEAR/3 (indicator* OR audit*))):ab,ti)
AND (‘hospital readmission’/de OR (readmiss* OR rehospital*
OR ((re OR return) NEAR/3 (hospital* OR admiss*))):ab,ti).
Studies were included when they were written in English,
focused on methodological aspects of readmission rates as a quality
indicator for hospital care and full texts were available. We
included only studies in major disease fields. Hence, studies
focusing on rare diseases, just describing readmission rates over
time or using readmissions as outcome measures of interventions
were excluded.
Of the references identified in the literature search, titles and
abstracts were screened and articles that did not meet the inclusion
criteria were excluded. The full text of the remaining potentially
eligible articles was reviewed to assess whether they should be
included. In case of doubt, the article was discussed among the
authors and if necessary, an independent researcher was consulted.
We discuss the methodological aspects that emerged from the
literature review that are important for the validity of the
readmission rates as an indicator of quality of care.
Results
Our search strategy resulted in 1609 unique references of which
titles and abstracts were screened. Based on title and abstract 1189
studies were excluded. Of the remaining 420 articles another 318
were excluded based on full text review (Figure 1). We provide a
detailed description of the included studies in the appendix S1,
and below we discuss the most important findings.
The context in which readmission rates are used
Prior to using the readmission rate as a measure of quality of
care, the context in which the indicator will be used needs to be
clearly defined. The rationale for using readmission rates is one
aspect of this context. The readmission rate can be used with the
primary aim to improve quality of care or rather for reasons of cost
control. Next, specification of the clinical processes of which
quality of care is assessed is important. Currently, readmission
rates are mostly intended to measure quality of care in hospitals.
Which implies that the risk of being readmitted is determined by
the quality of care delivered during the hospital stay. Yet, literature
shows that the conditions after patients’ discharge, like the
presence of a social network after discharge [14] as well as
patients’ capacity for managing their own care, influence the
likelihood of being readmitted [15,16]. As a result, hospitals pay
attention to improving transitional care [17–24], for instance by
patient education to prepare the patient for discharge and to
coordinate outpatient follow up [23]. Although such a transition
phase may help, the actual post-discharge phase is not really in a
hospital’s reach anymore. Another example are readmissions in
chronic diseases, such as heart failure. These patients are
readmitted often because of their comorbidities or because their
condition becomes too severe to be treated by the general
practitioner, irrespective from the quality of delivered care during
their hospital stay [1]. Hence, the quality of care processes
captured by readmission rates will often be broader than only in-
hospital care [25].
In summary, using readmission rates as a quality measure
requires a clear definition of the context, including the rationale of
measuring readmissions, the related care processes and the patient
groups.
Methodological aspects
Based on the literature we defined several methodological
aspects that need to be considered when using the readmission
rates as a quality indicator (table 1). These range from
fundamental issues like the definition and the effect of competing
outcomes, to more practical issues as the possibility to adjust for
case-mix and the data reliability. These issues and their effects will
be described in the next paragraphs. In the final paragraph we will
focus on studies that have specifically tested the validity of
readmission rates as a quality indicator.
Indicator definition
Type of readmission. The definition of readmissions deter-
mines the number of readmissions that will be counted (numer-
ator). Planned procedures, such as staged operations, are
readmissions that are not determined by quality of care and
therefore should not be included in the numerator of the quality
indicator [26,27]. However, this basic distinction is not always
made [28]. Hence, capture quality of care related readmissions
requires a more specific definition (such as disease specific or
emergency readmissions) rather than all-cause readmissions. [29].
A frequently suggested alternative is to count unplanned
readmission rates. However, not all unplanned readmissions are
a result of poor quality of care as certain complications cannot be
avoided. Research has shown that just about 25% of all
readmissions are avoidable/preventable. Therefore, ideally, the
addition on whether a readmission was avoidable/preventable.
Although high variation in overall readmission rate can be
observed, this is not the case for the rate of preventable
readmissions [2,29]. Therefore, ideally it is defined, whether a
readmission was avoidable/preventable (through proper care
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delivery) [28,30] but the judgment on the preventability of a
readmission remains subjective [2].
Time window. The time window after the index admission in
which admissions are regarded as readmissions is not consistently
defined in the literature. The indicator is generally calculated on
basis of readmissions within one month (28 days UK, 31 days
USA) regardless of the patient group and condition [28,31–33].
When choosing a time window, it needs to be considered that a too
short time window might miss related readmissions while a large
one increases the likelihood of included admissions unrelated to
the index admission. For example, in cancer surgery a longer time
frame would allow to provide a better overview of actual costs, but
it would also include readmissions due to disease progression
instead of poor quality of surgery [25]. Clearly, the type of disease
the patient was originally treated for is largely influencing the
optimal timeframe [32]. Therefore the timeframe for readmissions
should be defined per disease.
The effect of competing outcomes
Association with (in-hospital) mortality. Mortality can be
seen as a competing endpoint for readmissions: patients who die
will not be readmitted [34,35]. Therefore patients who died during
their hospital stay need to be excluded from the denominator of
the readmission rate. Further, hospitals with high 30-day in-
hospital mortality rates are not necessarily outliers on the
readmission rate as well [36]. Research showed that the link
between high readmission rates and mortality rates on hospital
level is limited. A ‘‘modest’’ inverse relationship was merely found
for heart failure patients, and no relation could be observed for
pneumonia and acute myocardial infarction, suggesting that the
two indicators measure different aspects of quality of care, which
are not strongly related [37]. Therefore different outcome
measures, such as the readmission rate and the mortality rate
should be brought in relation with each other to gain insight in
total hospital performance [36,37].
Association with length of in hospital stay. Length of stay
is generally decreasing, partly because of efficiency gaining
interventions, such as a ‘‘just-in-time bed availability system’’ to
increase the bed turnover ratio [38,39]. Research suggests a link
between length of stay and the risk of being readmitted [39–45].
For each day shorter in hospital, a 6% increase in likelihood of
readmission was found [40]. Other studies fail to confirm this link
[24,42,46–50], which might be due to inappropriate adjustment
for disease severity [41,51].
Case mix adjustment
The likelihood that a patient is readmitted is not only affected
by quality of care but also by characteristics of the patient.
Between-hospital differences in readmission rates may be caused
by differences in patient population and therefore readmission
rates need to be adjusted for patient characteristics. Although
many case-mix adjustment models for readmissions have been
developed, there is little consensus on which patient characteristics
affect the likelihood of a readmission [27,52]. Numerous studies,
varying in their methodology, geographical characteristics, patient
groups and considered variables, find different factors that increase
the risk of re-admission. In general, two patient groups seem to be
at a high risk of being readmitted: the sickest and poorest patients
[2,20,51,53,54]. However, these factors are often not included as
standard variables in case-mix adjustment models, as these models
are often based on administrative data and therefore miss detailed
clinical information.
In a review that evaluated 30 validated readmission risk
prediction models, the authors concluded that most models had
poor predictive ability. Almost all studies had c-statistics less than
0.70 [55], possibly due to missing demographic or clinical
variables. In a more recent paper, the prediction model reached
a higher predictive ability (c-statistic = 0.80) [41]. The authors
concluded however that information on demographics, SES, prior
utilization and diagnosis still had restricted predictive power [41].
Thus, current research provides limited guidance on which
variables should be included in models to adjust for case-mix
[41,55–57].
Figure 1. Flow chart of inclusion process.
doi:10.1371/journal.pone.0112282.g001
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Table 1. Overview of methodological aspects challenging the validity of readmission rates for benchmarking.
methodological aspect problem potential solution
Clinical setting readmission rates are thought to reflect
quality of hospital care (17–24)
care after discharge also influences
readmission(14, 25)
clear definition of the indicator, the patient
group and the clinical setting(hospital care,
integrated care) aimed to measure increase
insight in influence of post discharge phase/social
factors on readmissions(14)
relate readmission to other outcome measures
such as mortality, emergency department and
observation service use (14) evaluate home health
care/nursing home information (15)
indicator definition
Type of readmission missing distinction between planned/
unplanned procedures (2, 26–29)
inclusion of readmissions unrelated to
quality of care into the numerator (26)
leads to overestimation of the rate of
readmission (69)
specify definition of the indicator (27, 28, 31), define
disease-specific/emergency readmissions instead of
overall readmissions (2) include indication on
preventability/avoidability of readmission in
definition (2, 28–30)
time window no consistent definition of the time
window in which admission is
considered as readmission(28) generally
28–31 day time frame used regardless
of patient group/condition(31–33)
although 30 days seems generally
sufficient (31, 33), for certain conditions
it is a too short time window, while for
others it increases the likelihood of
including admissions unrelated to
index admission(25, 32)
evaluate time frame based on condition under
evaluation
effect of competing
outcomes
association with (in-
hospital) mortality
a group of patients who receive poor
quality of care are not readmitted,
because they die or recover
nevertheless (31, 34, 35)
not excluding patient who died from
the denominator leads to a potential
underestimation of rate of qoc related
readmission
exclude patients who died during hospital stay
from denominator link hospital data with death
statistics, exclude patients from denominator who
die outside hospital
relate the readmissions with mortality rate in order
to understand total hospital performance (36, 37)
association with length
of in-hospital mortality
a decreased length of hospital stay
increases readmissions (38, 39)
the exact mechanism with readmission
is inconclusive (24, 39, 40, 42–50)
further research to understand the mechanism
between length of stay and readmission
case mix adjustment
using administrative
data vs. clinical data
no consensus on which patient
characteristics affect readmission
likelihood(27, 52) two high risk groups
defined: the sickest and the poorest
(2, 51, 53, 54)
these factors are not standard variables
in risk prediction models as often not
available in administrative databases(36)
current risk prediction models perform
moderately (40)(39, 55–57)
apply proper case-mix adjustment for patient
characteristics including socioeconomic status and
disease severity(39, 51)
further research on risk prediction models including
linkage of primary care data and socioeconomic
information
data reliability
missing readmissions to
other institutions
patients are readmitted to institutions
other than index hospital (25, 35)
patients cannot always be followed
between centers; only readmissions to
same institutions are measured assessing
‘‘same hospital’’ readmissions, might
be underestimation of the real number
of readmissions(25)
further research on the proportion of patients
readmitted to other hospitals than index hospital
unique patient information to follow patients
between centers
coding coding practice influences the validity
readmission rates(30, 58, 77–84)
no conclusion on how to register
readmissions potentially related to
qoc in reliable way (2, 59–61)
missing distinction between planned/
unplanned procedures leads to
overestimation of real readmission
variation in coding leads to biased
comparison between hospitals
increase investment in performance measurement
systems(16) research on data reliability(28)
standardized data registry (electronic data
systems)(16, 62)
engagement of the provider in measurement,
analysis and interpretation of the indicator(16, 64)
completeness and
accuracy of data source
reliable data collection systems are
lacking(38) Readmissions are mainly
calculated based on administrative data
(16, 63) administrative data suffer from
inaccuracy, like non-exact/incomplete
registration of variables not relevant for
financial concerns(39, 40, 64–69)
incomplete registration may lead to
over/underestimation of real readmission
inaccurate indication of readmissions
related to qoc may lead to
overestimation of readmissions (64, 65)
aim for minimum data set with complete
registration
registration of unique patient identifying
information to enhance possibility for linking
data(such as pharmacy data)(70) enhancing linkage
opportunities increases possibility for better case-
mix adjustment
validity of readmission
rates as a quality measure
no gold standard on how to assess
qoc in the literature huge variation in
conclusions in regard to the validity
of the readmission indicator (71–113)
potentially invalid conclusions on qoc above described methodological conditions need
to be taken into account when further investigating
readmissions as a quality indicator
additional data gathering for further investigation
of outlier hospitals(93)
doi:10.1371/journal.pone.0112282.t001
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Data reliability
Missing readmissions to other institutions. Not all
patients are readmitted to the same center where they had their
index admission. This is mainly due to the centralization of
complex operations in tertiary centers, such as in oncology [25].
When patients unexpectedly develop complications and are
readmitted in their local center, they are not captured when only
readmissions to the ‘‘same hospital’’ are counted [25]. Missing
these patients leads to an underestimation of the true overall
readmission rate.
Coding. The coding practice within a hospital has an
essential impact on the validity of readmission rate as a quality
indicator [58]. The way a ‘‘planned’’ procedure is defined is
crucial for the comparability between hospitals. Ideally a planned
readmission is coded in the registration system, for example, with
an additional coding element ‘‘staged’’ at the index admission,
which would indicate that a follow-up procedure is planned [59].
Urgent readmissions are sometimes considered as a potential
proxy for the relatively subjective ‘avoidable readmissions’, as
these are coded, for example an admission through the ER.
Although low urgent readmission rates showed to be related to low
avoidable readmission rates [60] it was shown that the ‘‘avoid-
ability’’ of urgent readmissions also significantly varied by the time
from discharge, with early readmissions being more likely to be
avoidable [2,61].
Other causes for biased comparisons between hospitals are the
different and unspecific definitions of the type of readmissions
assessed, and variation in coding between hospitals. It is essential
who is in charge of the coding process. For example administrative
staff at the department or hospital level, the treating clinician, or
specialized data coders. The variation in coding practice may
affect both the readmission rates and the case-mix variables.
Completeness and accuracy of data source. Electronic
health records and health information exchange networks result in
more accurate and complete clinical data [62]. The major
information source to calculate the readmission rate is adminis-
trative data. The advantage of administrative data is that this data
is standard available and patient journeys can be followed (within
hospitals) [63]. Nevertheless, one major limitation of administra-
tive data is the data inaccuracy [64], which includes the non-exact
or incomplete registration of variables that are not relevant for
financial concerns [38,40,41]. Research showed that to a certain
degree administrative data captures similar information compared
to medical records, for example on all-cause readmissions [65–68].
However more specific information, like the identification of
unplanned readmissions or index procedure related readmissions,
showed to be more difficult to extract [66,69]. An accurate
indication of whether a readmission is a part of treatment or due to
a cancelled procedure and not a readmission related to a quality of
care problem, would enhance the reliability of the data source
[64,65].
The case-mix adjustment variables that have been investigated
so far are most often present in administrative databases.
However, clinical information such as disease severity is often
lacking limiting case-mix adjustment possibilities. The addition of
a unique patient identifier across different databases would
enhance the possibility for linking data, such as pharmacy data
[70] or clinical data. This would largely improve the possibilities
for more precise definitions of readmissions and better case-mix
adjustment.
Validity of readmission rates as a quality measure
No gold standard exists on how to assess quality of care. Usually
different hospital structures and processes and their relation with
patient outcomes are measured. The different definitions and
proxies used in studies to quantify quality of hospital care influence
whether an association between the readmission rate and ‘quality’
is found. For example, we found studies that relate readmissions to
hospital volume, but neither can be regarded as a ‘gold standard’
of hospital quality.
Furthermore, the methodological aspects we discussed have a
potential influence on the validity of the readmission rates as a
quality indicator. These may contribute to the huge variation in
conclusions with regard to the validity of readmission rates found
in the literature. Different studies in different patient groups and
conditions come to the conclusion that lower quality of hospital
care is linked to a higher number of readmissions [71–94].
Especially safety-related events (such as postoperative complica-
tions) show a relation with readmissions [71,95]. Rosen and
colleagues, who evaluated the correlation between patient safety
indicators and readmissions, showed that patients who experi-
enced a patient safety event had an increased risk of readmission
[71]. Nevertheless, there are also studies that are inconclusive [96–
101], show an inverse relationship [102,103] or no relationship at
all between readmission rate and in-hospital quality of care
[98,104–113]. Analysis of additionally collected data could help to
gain insight into outlier hospitals in order to understand driving
mechanisms behind high readmission rates [93].
Discussion
This review aimed to summarize the methodological aspects
that need to be considered when using the readmission rate as a
measure for quality of hospital care for external purposes. We
found that the validity of readmission rates as a quality indicator is
influenced by the clinical process that is assessed, the indicator
definition, the extend of case-mix correction, the effect of
competing outcomes and the data reliability. Ignoring or poorly
handling these aspects may lead to a biased estimation of the
overall readmission rate and a biased comparison of readmission
rates between hospitals. As a result of variance in handling these
methodological threats, studies on the validity of readmission rates
as a quality indicator reach conflicting conclusions. We conclude
that given the limitations of readmission rates, they need to be
used with caution as a measure of in-hospital quality, even more
when used as a tool for a pay for performance scheme.
Some of the discussed factors concerning the readmission rate
could in principal be improved by investing resources in accurate
data registry and refinements of indicator description. For
instance, by using unique patient identifiers to follow patients
across centers. That would help to avoid missing readmissions to
other institutions. Another option would be to flag planned
admissions, which are a part of the treatment plan or due to
cancelled procedures, to measure just the quality of care related
readmissions.
Other problems, such as the competing endpoint ‘‘mortality’’
are more complex. Patients who died in hospital need to be
excluded from the patient group forming the denominator to
calculate the readmission rate, as they are not at risk any more to
be readmitted. These deaths are captured in the mortality rate.
Therefore it is essential to combine outcome in order to provide a
more complete picture of the quality of hospital care.
Nevertheless there are theoretical considerations whether a
readmission is an indication of bad quality of care. First, a
readmission is obviously a more positive outcome than dying.
Secondly, if there is for example a chance of six percent that a
complication occurs after discharge, it would mean that 100
patients need to be admitted longer, to avoid a complication in six
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patients [114]. It can be questioned whether by a longer length of
hospital stay a complication really can be avoided or only detected
at an earlier stage. It is also possible to inform the patient on the
risk of developing a complication and decide together how to
continue. Furthermore, it needs to be taken into account that
readmissions are not always solely determined by quality of
hospital care. For certain diseases, like heart failure, the patient’s
condition is the major driver behind repeated admissions. Patients
with low socioeconomic status, elderly and patients with co-
morbidities are at high risk of getting readmitted. Therefore case-
mix adjustment is essential. Furthermore, the role of facilities
outside the hospital and after the 30day time window, like
community services, need to be involved in the conceptual
framework of readmissions. When aiming to improve quality of
care (in and outpatient) increased integration and cooperation
between primary and secondary care is needed.
The literature study revealed inconclusive results for some
methodological aspects, such as the relation with length of stay, or
patient characteristics. The studies we assessed investigated
different patient populations and often were based on hospital
administrative data. A recent high quality study which was not
included in our review investigated surgical readmissions of
479,471 patients from 3004 hospitals. The authors found that
higher surgical volume was significantly related with lower
composite readmission rates (upper volume quartile 12.7% vs.
lower volume quartile 16.8% P,0.0001), and hospitals with the
lowest surgical mortality rates had significantly lower readmission
rates (lower mortality quartile 13.3% vs. upper mortality quartile
14.2% P,0.0001). But high adherence to surgical process
measures was only marginally linked with lower readmission rates
(highest quartile vs. lowest quartile, 13.1% vs. 13.6%; P= 0.02),
showing that it is still unclear whether low readmission rates are
the result of good quality [115].
Furthermore, the risk of getting readmitted is also varying
between patient groups and conditions. This supports the idea that
outcome measures, like the readmission rate, are not a one size fits
all measure. Even if quality of hospital care and the transition
phase can potentially be improved, readmissions might be a more
applicable measure for certain diseases than for others. For
chronic diseases, where planned admissions are part of treatment
strategies, readmissions are a less suitable performance measure.
At least not until generally used data systems can identify planned
admissions with high certainty. It requires clinical knowledge to
determine whether (avoidable) readmissions may theoretically
represent poor quality of care for specific diseases. Consequently
more research is needed to build reliable algorithms to identify
avoidable readmissions.
In sum, avoidable readmissions are of high relevance, as they
are an adverse event to patients and family and are a high financial
burden for healthcare systems. The assessment of the indicator
shows difficulties, as the indicator definition is often not explicit
enough to identify readmissions related to quality of care
(avoidable readmissions). The data used to calculate the indicator
is mainly administrative data, which generally includes incomplete
and inaccurate data elements and lacks clinical information.
Furthermore, in many countries readmissions to other institutions
cannot be followed. Readmission rates are influenced also by other
factors than quality of hospital care, which include length of stay,
(in-hospital) mortality and patient characteristics. The magnitude
of influence is partly not know as data is missing to investigate the
association (e.g. no post discharge mortality, no clinical charac-
teristics). Further, the scientific evidence of the indicator is limited,
as existing research shows conflicting results with regard to the
influence of quality of hospital care on the readmission rate (see
Appendix S1). This, however, could be related to the prior
mentioned methodological aspects that are variously.
Using outcome measures externally to measure and compare
hospital performance has consequences. When financial conse-
quences are linked to the outcome, unintended effects could occur.
For example, hospitals may try to reduce their readmission to
escape the penalty of exceeding the readmission rate by lowering
admissions, moving readmissions after the 30-day window, or risk-
avoidance in regards to high risk groups. These gaming efforts
might reduce the focus on the actual intention: improving quality
of hospital care.
A measure used for external purposes should be underpinned
with solid evidence for its validity. However, the link between
readmissions and the quality of hospital care seems not to be fully
explained yet. Still, this does not imply that there is no room for
improvement for hospitals in their readmission rate and the
indicator could not be useful for internal use. Research should
continue to gain insight in the driving mechanisms behind
readmissions for the different conditions to improve our under-
standing how the readmission rate is a part of the quality of
hospital care picture. In addition, the readmission rate needs to be
brought into relation with other outcome indicators, and hence
considered as part of a bundle, to understand all aspects of hospital
performance [36].
The methodological aspects we identified need to be considered
when using readmission rates as quality indicator. The use of
readmission rates for external quality purposes, such as for pay for
performance requires strict methodological criteria to avoid
confounding. At its current state the rate of readmission does
not fulfill the methodological requirements of a reliable and valid
indicator. Therefore the indicator should not be used for external
purposes. As this is nevertheless currently happening, readmission
rates should be interpreted with great caution.
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